HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Leo I Gordon Selected Research

Yttrium

9/2007Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
5/2007Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan.
4/2006Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma.
12/2004Antilymphoma treatments given subsequent to Yttrium 90 ibritumomab tiuxetan are feasible in patients with progressive non-Hodgkin's lymphoma: a review of the literature.
10/2004Radioimmunotherapy in non-Hodgkin's lymphoma: trials of yttrium 90-labeled ibritumomab tiuxetan and beyond.
9/2004Yttrium 90-labeled ibritumomab tiuxetan radioimmunotherapy produces high response rates and durable remissions in patients with previously treated B-cell lymphoma.
2/2004Efficacy and safety of radioimmunotherapy with yttrium 90 ibritumomab tiuxetan (Zevalin).
2/2002Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Leo I Gordon Research Topics

Disease

33Non-Hodgkin Lymphoma (Lymphosarcoma)
09/2015 - 02/2002
31Neoplasms (Cancer)
11/2015 - 05/2002
25Lymphoma (Lymphomas)
12/2015 - 04/2003
10Hodgkin Disease (Hodgkin's Disease)
06/2015 - 06/2007
9Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
04/2015 - 06/2004
8Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
10/2013 - 07/2005
7Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
09/2015 - 02/2008
5Hematologic Neoplasms (Hematological Malignancy)
01/2015 - 07/2005
4B-Cell Lymphoma (Lymphoma, B Cell)
02/2013 - 06/2004
4Multiple Myeloma
01/2013 - 02/2002
3Genetic Translocation (Chromosomal Translocation)
09/2015 - 09/2013
3Thrombocytopenia (Thrombopenia)
03/2013 - 06/2002
3Lymphoproliferative Disorders (Lymphoproliferative Disorder)
11/2010 - 07/2008
2Anoxia (Hypoxia)
01/2013 - 05/2008
2Leukemia
01/2013 - 09/2012
2Burkitt Lymphoma (Burkitt's Lymphoma)
12/2012 - 07/2012
2Acute Promyelocytic Leukemia
09/2012 - 02/2002
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2007 - 04/2003
2Neutropenia
06/2007 - 07/2005
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
07/2005 - 11/2004
1Cardiovascular Diseases (Cardiovascular Disease)
01/2015
1Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
07/2014
1Pancreatitis
05/2014
1Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
10/2013
1Starvation
02/2013
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
01/2013
1Splenomegaly
07/2012
1Epstein-Barr Virus Infections
07/2012

Drug/Important Bio-Agent (IBA)

23rituximab (Mabthera)FDA Link
04/2015 - 05/2002
19ibritumomab tiuxetan (Zevalin)FDA Link
10/2009 - 02/2002
8YttriumIBA
09/2007 - 02/2002
5bortezomib (Velcade)FDA Link
08/2014 - 05/2009
4Cyclin D1IBA
09/2015 - 08/2011
4Vincristine (Oncovin)FDA LinkGeneric
06/2015 - 04/2009
4Prednisone (Sone)FDA LinkGeneric
06/2015 - 04/2009
4Doxorubicin (Adriamycin)FDA LinkGeneric
06/2015 - 06/2012
4Bleomycin (Blenoxane)FDA LinkGeneric
06/2015 - 06/2007
4arsenic trioxide (Trisenox)FDA Link
01/2013 - 02/2002
4motexafin gadoliniumIBA
04/2010 - 02/2005
3Dacarbazine (DIC)FDA LinkGeneric
06/2015 - 02/2013
3Vinblastine (Vinblastine Sulfate)FDA Link
06/2015 - 02/2013
3Proteins (Proteins, Gene)IBA
01/2015 - 04/2010
3Lipoproteins (Lipoprotein)IBA
01/2015 - 02/2013
3DNA (Deoxyribonucleic Acid)IBA
05/2013 - 12/2012
3Reactive Oxygen Species (Oxygen Radicals)IBA
05/2009 - 02/2005
2bevacizumabFDA Link
12/2015 - 06/2006
2Etoposide (VP 16)FDA LinkGeneric
06/2015 - 04/2013
2Mechlorethamine (Nitrogen Mustard)FDA Link
06/2015 - 04/2013
2Monoclonal AntibodiesIBA
01/2015 - 05/2007
2CholesterolIBA
01/2015 - 02/2013
2ParaffinIBA
02/2013 - 10/2012
2Formaldehyde (Formol)FDA Link
02/2013 - 10/2012
2CRA 024781IBA
01/2013 - 05/2009
2Phosphotransferases (Kinase)IBA
09/2012 - 01/2009
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2012 - 04/2009
2CurcuminIBA
08/2011 - 04/2011
2Glutathione (Reduced Glutathione)IBA
08/2010 - 07/2005
2purineIBA
09/2007 - 11/2004
1Apolipoprotein A-I (Apolipoprotein A1)IBA
08/2015
1Carbon MonoxideIBA
06/2015
1Nucleic AcidsIBA
01/2015
1HDL LipoproteinsIBA
01/2015
1Biological Markers (Surrogate Marker)IBA
10/2014
14-trifluoromethylsalicylic acid (HTB)IBA
08/2014
1anaplastic lymphoma kinaseIBA
07/2014
1cAC10-vcMMAEIBA
05/2014
1gemcitabineFDA Link
10/2013
1GoldIBA
02/2013
1Scavenger Receptors (Scavenger Receptor)IBA
02/2013
1high density lipoprotein receptorsIBA
02/2013
1Histone Deacetylase InhibitorsIBA
01/2013
1AdenineFDA LinkGeneric
01/2013
1Chloroquine (Aralen)FDA LinkGeneric
01/2013
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
01/2013
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2013
1GlucocorticoidsIBA
01/2013
1CytotoxinsIBA
01/2013
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2013
1Transcription Factors (Transcription Factor)IBA
01/2013
1Glucocorticoid Receptors (Glucocorticoid Receptor)IBA
01/2013
1Serum AlbuminIBA
11/2012
1Protein Kinases (Protein Kinase)IBA
09/2012
1Protein Kinase CIBA
09/2012
1Immunoconjugates (Immunoconjugate)IBA
08/2012
1Nasopharyngeal carcinomaIBA
07/2012
1dasatinib (BMS 354825)FDA Link
07/2012
1Topotecan (Hycamtin)FDA LinkGeneric
06/2012

Therapy/Procedure

16Drug Therapy (Chemotherapy)
01/2015 - 06/2002
14Radioimmunotherapy
07/2011 - 02/2002
5Transplants (Transplant)
09/2014 - 02/2008
4Aftercare (After-Treatment)
05/2009 - 04/2003
3Stem Cell Transplantation
11/2015 - 10/2013
2Combination Drug Therapy (Combination Chemotherapy)
06/2015 - 11/2013
2Radiotherapy
06/2015 - 04/2015
2Immunotherapy
01/2015 - 05/2002
2Hematopoietic Stem Cell Transplantation
11/2013 - 04/2010
2Heterologous Transplantation (Xenotransplantation)
02/2013 - 07/2011
1Lymphatic Irradiation
06/2014
1Individualized Medicine
01/2013
1Intravenous Infusions
08/2012